EFTA00316579.pdf

"p h Quest Report Status: Partial vy Diagnostics EPSTEIN, JEFFREY Patient Information Specimen Information Client Information — Specimen: MR9529575 Client #: 17436 56W5265 EPSTEIN, JEFFREY Requisition: 0012348 UCA/MOSKOWITZ BRUCE MD DOB: 01/20/1953 AGE: 60 Attn: **P GR/UNIV.CLINICAL Gender: M 1411 N FLAGLER DR STE 7100 Collected: 12/30/2013 Phone: 561.366.0084 WEST PALM BEACH, FL 33401 Received: 12/31/2013 I 00:27 EST Patient ID: 090443348 Reported: 01/02/2014 I 13:31 EST Health ID: 8573003290851249 Test Name In Range Out Of Range Reference Range Lab HEPATITIS PANEL, ACUTE W/REFLEX TO CONFIRMATION HEPATITIS A IGM NON-REACTIVE NON-REACTIVE MI HEPATITIS B SURFACE MI ANTIGEN W/REFL CONFIRM HEPATITIS B SURFACE ANTIGEN NON-REACTIVE NON-REACTIVE HEPATITIS B CORE MI ANTIBODY (IGM) NON-REACTIVE NON-REACTIVE HEPATITIS C ANTIBODY NON-REACTIVE NON-REACTIVE MI SIGNAL TO CUT-OFF 0.02 <1.00 LIPID PANEL CHOLESTEROL, TOTAL 217 H 125-200 mg/dL MI HDL CHOLESTEROL 28 L > OR 40 mg/dL MI TRIGLYCERIDES 474 H <150 mg/dL MI LDL-CHOLESTEROL <130 mg/dL (talc) MI LDL cholesterol not calculated. Triglyceride levels greater than 400 mg/dL invalidate calculated LDL results. Desirable range <100 mg/dL for patients with CHD or diabetes and <70 mg/dL for diabetic patients with known heart disease. CHOL/HDLC RATIO 7.8 H < OR = 5.0 (talc) MI NON HDL CHOLESTEROL 189 H mg/dL (talc) MI Target for non-HDL cholesterol is 30 mg/dL higher than LDL cholesterol target. CARDIO CRP(R) 0.7 mg/L MI Lower relative cardiovascular risk according to AHA/CDC guidelines. For ages >17 Years: cCRP mg/L Risk According to AHA/CDC Guidelines <1.0 Lower relative cardiovascular risk. 1.0-3.0 Average relative cardiovascular risk. 3.1-10.0 Higher relative cardiovascular risk. Consider retesting in 1 to 2 weeks to exclude a benign transient elevation in the baseline CRP value secondary to infection or inflammation. >10.0 Persistent elevation, upon retesting, may be associated with infection and inflammation. HONOCYSTEINE, MI CARDIOVASCULAR 16.6 H <11.4 umol/L COMPREHENSIVE METABOLIC MI PANEL GLUCOSE 114 H 65-99 mg/dL CLIENTSERVICES:866.697.8378 SPECIMEN: MR9529575 PAGEI0F5 Quest. Quest Diagnostics. the associated logo and all associated Quest Diagnostics marks are the trademarks of Quest Diagnostics. EFTA00316579  ain Quest Report Status: Partial eP r Diagnostics EPSTEIN, JEFFREY Patient Information Specimen Information Client Information Specimen: MR9529575 Client #: 17436 EPSTEIN, JEFFREY Collected: 12/30/2013 DOB: 01/20/1953 AGE: 60 Received: 12/31/2013 /00:27 EST Gender: M Reported: 01/02/2014 13:31 EST Patient ID: 090443348 Health ID: 8573003290851249 Test Name In Range Out Of Range Reference Range Lab Fasting reference interval UREA NITROGEN (BUN) 19 7-25 mg/dL CREATININE 0.94 0.70-1.25 mg/dL For patients >49 years of age, the reference limit for Creatinine is approximately 13% higher for people identified as African-American. eGFR NON-AFR. AMERICAN 88 > OR = 60 mL/min/1.73m2 eGFR AFRICAN AMERICAN 102 > OR = 60 mL/min/1.73m2 BUN/CREATININE RATIO NOT APPLICABLE 6-22 (calc) SODIUM 140 135-146 mmol/L POTASSIUM 4.6 3.5-5.3 mmoi/L Results slightly increased due to hemolysis. CHLORIDE 106 98-110 mmol/L CARBON DIOXIDE 23 19-30 mmol/L CALCIUM 9.8 8.6-10.3 mg/dL PROTEIN, TOTAL 6.9 6.1-8.1 g/dL ALBUMIN 4.2 3.6-5.1 g/dL GLOBULIN 2.7 1.9-3.7 g/dL (calc) ALBUMIN/GLOBULIN RATIO 1.6 1.0-2.5 (calc) BILIRUBIN, TOTAL 0.9 0.2-1.2 mg/dL ALKALINE PHOSPHATASE 58 40-115 U/L AST 19 10-35 U/L ALT 23 9-46 U/L URIC ACID 7.1 4.0-8.0 mg/dL MI Therapeutic target for gout patients: <6.0 mg/dL PROTEIN, TOTAL AND PROTEIN ELECTROPHORESIS PROTEIN, TOTAL, SERUM MI PROTEIN, TOTAL 6.9 6.1-8.1 g/dL PROTEIN ELECTROPHORESIS MI ALBUMIN 3.9 3.5-4.7 g/dL ALPHA-1-GLOBULINS 0.2 0.1-0.3 g/dL ALPHA-2-GLOBULINS 0.9 0.5-1.0 g/dL BETA GLOBULINS 0.9 0.8-1.4 g/dL GAMMA GLOBULINS 1.0 0.6-1.6 g/dL INTERPRETATION Protein electrophoresis pattern appears normal. LD 182 120-250 U/L MI TSH 1.12 0.40-4.50 mIU/L MI T4 (THYROXINE), TOTAL 7.6 4.5-12.0 mcg/dL MI FREE T4 INDEX (T7) 2.4 1.4-3.8 T3 UPTAKE 31 22-35 % MI SED RATE BY MODIFIED MI WESTERGREN 2 < OR = 20 mm/h URINALYSIS, COMPLETE Soo Endnote 2 CBC (INCLUDES DIFF/PLT) MI WHITE BLOOD CELL COUNT 3.9 3.8-10.8 Thousand/uL RED BLOOD CELL COUNT 5.02 4.20-5.80 Million/uL HEMOGLOBIN 14.8 13.2-17.1 g/dL CLIENn'SERIMES:866.6971378 SPECIMEN: MR9529575 PAGE 2OF 5 Quest. Quest Diagnostics, the associated logo and all associated Quest Diagnostics marks are the trademarks of Quest Diagnostics. EFTA00316580  Aopia (1est Report Status: Partial eP r Diagnostics EPSTEIN, JEFFREY Patient Information Specimen Information Client Information Specimen: MR9529575 Client #: 17436 EPSTEIN, JEFFREY Collected: 12/30/2013 DOB: 01/20/1953 AGE: 60 Received: 12/31/2013 /00:27 EST Gender: M Reported: 01/02/2014 13:31 EST Patient ID: 090443348 Health ID: 8573003290851249 Test Name In Range Out Of Range Reference Range Lab HEMATOCRIT 43.7 38.5-50.0 % MCV 86.9 80.0-100.0 fL MCH 29.5 27.0-33.0 pg MCHC 33.9 32.0-36.0 g/dL RDW 13.5 11.0-15.0 % PLATELET COUNT 241 140-400 Thousand/uL DIFFERENTIAL, MANUAL MI ABSOLUTE NEUTROPHILS 936 L 1500-7800 cells/uL ABSOLUTE LYMPHOCYTES 2340 850-3900 cells/uL ABSOLUTE MONOCYTES 195 L 200-950 cells/uL ABSOLUTE EOSINOPHILS 390 15-500 cells/uL ABSOLUTE BASOPHILS 39 0-200 cells/uL NEUTROPHILS 24 LYMPHOCYTES 60 MONOCYTES EOSINOPHILS 10 BASOPHILS 1 CBC MORPHOLOGY NORMAL Review of peripheral smear confirms automated results. Although an "automated CBC" was ordered, our instrumentation detected an abnormality on your patient's specimen requiring us to perform a manual review. VITAMIN B12 369 200-1100 pg/mL MI Please Note: Although the reference range for vitamin B12 is 200-1100 pg/mL, it has been reported that between 5 and 10% of patients with values between 200 and 400 pg/mL may experience neuropsychiatric and hematologic abnormalities due to occult B12 deficiency; less than 1₹ of patients with values above 400 pg/mL will have symptoms. C-REACTIVE PROTEIN <0.10 <0.80 mg/dL MI Please be advised that patients taking Carboxypenicillins may exhibit falsely decreased C-Reactive Protein levels due to an analytical interference in this assay. CORTISOL, TOTAL 9.3 mcg/dL MI Reference Range: For 8 a.m.(7-9 a.m.) Specimen: 4.0-22.0 Reference Range: For 4 III.(3-5 p.m.) Specimen: 3.0-17.0 * Please interpret above results accordingly * TESTOSTERONE, TOTAL, MALES 163 L ng/dL MI Reference Range Adult 241-827 Aging men with clinically significant hypogonadal symptoms and testosterone values repeatedly in the range of 200-300 ng/dL or less, may benefit from testosterone treatment after adequate risk and benefits counseling. In hypogonadal males, Testosterone, Total, LC/MS/MS, is the recommended assay. This test code (15983) must be collected in a red-top tube with no gel. The CLIENT SERVICES: 866.697.8378 SPECIMEN: MR9529575 PAGE30F5 Quest. Quest Diagnostics. the associated logo and all associated Quest Diagnostics marks are the trademarks of Quest Diagnostics. EFTA00316581  Quest Report Status: Partial Diagnostics, an EPSTEIN, JEFFREY Patient Information Specimen Information Client Information Specimen: MR9529575 Client #: 17436 EPSTEIN, JEFFREY Collected: 12/30/2013 DOB: 01/20/1953 AGE: 60 Received: 12/31/2013 / 00:27 EST Gender: M Reported: 01/02/2014 / 13:31 EST Patient ID: 090443348 Health ID: 8573003290851249 Test Name In Range Out Of Range Reference Range Lab Endocrine Society recommends obtaining at least two morning (8-10 a.m.) samples on different days when screening for hypogonadism. PSA, TOTAL 0.5 < OR = 4.0 ng/mL MI This test was performed using the Siemens chemiluminescent method. Values obtained from different assay methods cannot be used interchangeably. PSA levels, regardless of value, should not be interpreted as absolute evidence of the presence or absence of disease. Endnote I * Test not performed. * No urine received. CLIENT SERVICES: 866.697.8378 SPECIMEN: MR9529575 PAGE 4 OF 5 Quest. Quest Diagnostics, the associated logo and all associated Quest Diagnostics marks are the trademarks of Quest Diagnostics. EFTA00316582  gsisk Quest Report Status: Partial a , Diagnostic, EPSTEIN, JEFFREY Patient Information Specimen Information Client Information Specimen: MR9529575 Client #: 17436 EPSTEIN, JEFFREY Collected: 12/30/2013 DOB: 01/20/1953 AGE: 60 Received: 12/31/2013 /00:27 EST Gender: M Reported: 01/02/2014 13:31 EST Patient ID: 090443348 Health ID: 8573003290851249 RHEUMATOID ARTHRITIS REPORT ANA IFA SCREEN W/REFL TO TITER AND PATTERN, IFA Lab: MI Test Name Results Reference Range ANA SCREEN. IFA NEGATIVE NEGATIVE PENDING TESTS: VITAMIN D. 25-HYDROXY. LOMS/MS LYME DISEASE ANTIBODIES (IGG.IGM). IMMUNOBLOT IMMUNOFIXATION. SERUM HIV At HIV If2. EIA, WITH REFLEXES PERFORMING SITE: MI QUEST DIAGNOSTICS.MIAMI. 10200 COMMERCE PARKWAY. MIRAMAR. FL 33025.3938 Laboraimy Director: GLEN L HORTIN MD PHD. CL1A: I 0D027733.1 CLIENT SERVICES: 866.697.8378 SPECIMEN: MR9529575 PAGE 5 OF 5 Quest. Quest Diagnostics, the associated logo and all associated Quest Diagnostics marks are the trademarks of Quest Diagnostics. EFTA00316583